Douglas Berger Psychiatrist Tokyo – About Dr. Douglas Berger

Douglas-Berger-Tokyo-psychiatrist
Douglas Berger psychiatrist Tokyo

Dr. Douglas Berger, M.D., Ph.D., Meguro Counseling Center Director

Douglas Berger, M.D., Ph.D., a fully bilingual American board certified psychiatrist, is the Director of the Tokyo Meguro Counseling Center. Dr. Doug Berger is a graduate of New York Medical College where he completed a 4-year residency program in psychiatry. He then finished a fellowship in Psychosomatic Medicine at the Albert Einstein College of Medicine. Now based in Tokyo, he had served on the Faculty of the Albert Einstein College of Medicine Department of Psychiatry in New York as an Assistant Professor of Psychiatry and licensed practicing U.S. physician. Dr. Berger’s Japanese qualifications include a Ph.D. from the University of Tokyo School of Medicine received for psychiatric research done while at the Tokyo University Department of Psychosomatic Medicine.

Dr. Berger came to Japan as a medical exchange student and psychiatric researcher at the Tokai University School of Medicine on a research fellowship from the Matsumae International Foundation. He later returned to Japan to do further psychiatric research at the Tokyo University Department of Psychosomatic Medicine and the Tokyo Institute of Psychiatry. Dr. Berger speaks native-level Japanese and regularly conducts psychotherapy for mixed-cultural couples as well as the local Japanese community. This page lists Dr. Berger’s research activity, and this page is an archive of community education articles for the Tokyo Families Magazine written by Dr. Berger. See what we write about on Twitter: Dr. Berger’s Twitter Page Meguro Counseling Center Twitter Page.

Dr. Berger also works extensively with children as Director of the Tokyo Child & Adolescent Counseling Service. Dr. Berger is a legal permanent resident of Japan.

Credential Verifications

Dr. Berger’s medical degree is from the United States, he is well-versed in the use of psychiatric medication and can guide the use of psychiatric medications integrated with psychotherapy through the physicians affiliated with his counseling practice (he does not directly practice medical care in Japan). Further information on Dr. Berger can be seen on his personal home page.

Publications by Dr. Douglas Berger, psychiatrist in Tokyo

Berger D: DOUBLE-BLINDING AND BIAS IN MEDICATION AND COGNITIVE-BEHAVIORAL THERAPY TRIALS FOR MAJOR DEPRESSIVE DISORDER, F1000Research 2016, 4:638 (doi: 10.12688/f1000research.6953.2). U.S. National Library of Medicine version.

Berger D: DOUBLE BLINDING REQUIREMENT FOR VALIDITY CLAIMS IN COGNITIVE-BEHAVIORAL THERAPY INTERVENTION TRIALS FOR MAJOR DEPRESSIVE DISORDER. Analysis of Hollon S, et al., Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial, F1000Research 2015, 4:639 (doi: 10.12688/f1000research.6954.1). U.S. National Library of Medicine version.

Articles by Douglas Berger, M.D., Ph.D. for Tokyo Families magazine.

Click here to see a full list of articles.

For more information on Dr. Doug Berger, read some of the articles here.

To contact Douglas Berger psychiatrist Tokyo please click here

Lithium for Alzheimers? https://t.co/9gC8ZvuTb0. Short 1.5 year follow up, treatment effect did not improve in the final 3 months. No head-to-head comparison vs memantine etc: https://t.co/blnRLs1xnq. Minor effect require careful modesty. Us: https://t.co/thlOKZInxr

Our Twitter posts are growing: @megurocounselng, @Douglas_Berger1, @Counsel_Tokyo. Please visit these feeds to see our commentary on news and research related to psychiatry, psychology, and our mental health counseling practice in Tokyo Japan.

We treat children, adolescents, and adults. The most common problems are depression & anxiety, ADHD, alcohol use disorders, personality problems and interpersonal problems: https://t.co/Cq2lOlCxaL

Most FDA black box's are great but the one on antidepressants and suicide in children and adolescents were found to be untrue & actually increased suicide attempts. So far, the FDA has refused to accept the evidence: https://t.co/lw9HWItoUL. Us: https://t.co/Jg8Gs54tBG

Anti-methamphetamine article ghost-written by NIDA for NIDA-supported researcher Dr. Moszcynska: https://t.co/B9eZJmAKSg claims no conflict of interest & aims to curb amphetamine prescriptions. Funding by NIDA with taxpayer money needs transparency. Us: https://t.co/LhXrtHgwaT

Load More...

Direct exam doesn’t raise the validity of a psychiatric diagnosis which is based on subjective categories: https://t.co/UtUzgeHQry. POPULATIONS of a diagnosis have more neurologic findings vs normals but that doesn’t help diagnose an INDIVIDUAL. Us: https://t.co/9aRvyKD62E

Gender Identity: personal sense of one's gender. Biology is a strong factor, socialization plays a role: https://t.co/R18jBLIQa3. 0.3% of the US identifies as transgender (TG): https://t.co/iNJsDobn3w. TG persons should be destigmatized w/equal rights. Us: https://t.co/22ATcUhzv1

Interjecting important medical information: CAR-T cell therapy for solid tumors: https://t.co/vOeEpl8eri. Making strides in antigen-targeted oncology treatments. Us: https://t.co/rki2U75koq

The Tarasoff rule is on potential for harm that others besides the therapist do not know: https://t.co/UtUzgeHQry. For political figures, everyone knows what may or may not happen, there is no secret or a diagnoses that a therapist needs to tell. Us: https://t.co/oI7l79bRSG

The government's regulations do favor the rich: https://t.co/NUFFaYLrEX, but the quality of life of the middle class is the correct value to look at, not the top 1%. The middle class's standard of living is improving: https://t.co/5pNWsAqDpX. Us: https://t.co/CcbDgs5z45

Load More...